Stevens-Johnson syndrome
O. Yu Olisova , O. V Grabovskaya , N. P Teplyuk , A. A Lepekhova , D. V Ignatiev , Kseniya V. Ignatieva
Russian Journal of Skin and Venereal Diseases ›› 2016, Vol. 19 ›› Issue (4) : 216 -220.
Stevens-Johnson syndrome
The literature review of the epidemiology, etiology and pathogenesis, clinical presentation and diagnosis of the syndrome of Stevens-Johnson severe life-threatening disease characterized by extensive lesions of the skin and mucous membranes, fever and bone and muscle aches, often induced by medication is presented. A review on the methods of treatment and prevention of this disease is presented. The clinical case of patient with the syndrome of Stevens-Johnson is described. The successful treatment of Syndrome Stevens-Johnson with high-dose systemic glucocorticoids was performed.
Stevens-Johnson syndrome / systemic glucocorticosteroids
| [1] |
Заславский Д.В., Горланов И.А., Самцов А.В., Хайрутдинов В.Р. Федеральные клинические рекомендации по ведению больных cиндромом Стивенса-Джонсона/токсическим эпидермальным некролизом. М.: Российское общество дерматовенерологов и косметологов; 2013. |
| [2] |
Harr T., French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet. J. Rare Dis. 2010; 5: 39-50. doi: 10.1186/1750-1172-5-39. |
| [3] |
Miliszewski M.A., Kirchhof M.G., Sikora S., Papp A., Dutz J.P. Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention. Am. J. Med. 2010; 123(3): 22-40. |
| [4] |
Lu N., Rai S.K., Terkeltaub R., Kim S.C., Menendez M.E., Choi H.K. Racial disparities in the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Semin. Arthritis. Rheum. 2016. pii: S0049-0172(16)30004-X. doi: 10.1016/j.semarthrit.2016.03.014. |
| [5] |
Chung W.H., Hung S.I. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol. Inter. 2010; 59(4): 325-32. |
| [6] |
French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Allergol. Inter. 2006; 55(1): 9-16. |
| [7] |
Ho H.H.F. Diagnosis and management of Stevens-Johnson Syndrome and toxic epidermal necrolysis. HongKong Med. Diary. 2008; 13(10): 17-20. |
| [8] |
Kardaun S.H., Jonkman M.F. Dexamethasone pulse therapy for Stevens-Johnson Syndrome/toxic epidermal necrolysis. Acta Derm. Venereol. 2007; 87(2): 144-8. |
| [9] |
Momin S.B. Review of intravenous immunoglobulin in the treatment of Stevens-Johnson Syndrome and toxic epidermal necrolysis. J. Clin. Aesthet. Dermatol. 2009; 2(2): 51-8. |
| [10] |
Григорьев Д.В. Многоформная экссудативная эритема, синдром Стивенса-Джонсона и синдром Лайелла - современная трактовка проблемы. Русский медицинский журнал. Дерматология. 2013; 21(22): 1073-83. http://www.rmj.ru/articles/dermatologiya/Mnogoformnaya_ekssudativnaya_eritema_sindrom_StivensaDghonsona_i_sindrom_Layella_sovremennaya_traktovka_problemy/#ixzz4G5NNRx8f |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
